fda drug safety communication semaglutide naion 2025 A new study looked at almost 32,000 adverse event Trending Topics & Drug Approvals:

Jayne Gavrity Senior Device Engineer, AstraZeneca Jayne Gavrity is a biomedical engineer with 10+ years in medical devices and combination products

As weve discussed above, GLP-1 is a hormone that is released from our small intestines in response to food

This medication works by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and promotes satiety

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea

Less common side effects Beyond the gastrointestinal basics, tirzepatide can cause other effects that catch some members off guard: Fatigue is reported by a meaningful subset of users, particularly in the early weeks